Irbesartan Plus Hct Hennig

Irbesartan and Hydrochlorothiazide, the active ingredients in Irbesartan Plus Hct Hennig, are an angiotensin II receptor blocker and a thiazide diuretic presented as oral tablets for systemic use. They treat hypertension in adult patients by lowering blood pressure through vascular relaxation and reduced fluid volume.

GNH USA supplies Irbesartan Plus Hct Hennig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for efficient global distribution.

Irbesartan plus Hydrochlorothiazide acts on the renin‑angiotensin‑aldosterone system and renal sodium handling to control high blood pressure.

Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. Essential hypertension: provides consistent blood‑pressure control when monotherapy is insufficient. Diastolic hypertension: improves diastolic control while maintaining target systolic levels.

Irbesartan plus Hydrochlorothiazide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased frequency of urination - Electrolyte disturbances such as low potassium - Mild fatigue - Transient nausea

Serious or Rare Side Effects: - Severe dehydration - Acute kidney injury - Angioedema or severe hypotension - Hyperkalemia - Persistent severe hyponatremia

When prescribing Irbesartan Plus Hct Hennig, clinicians should consider several safety measures. - Monitor blood pressure regularly: ensure therapeutic targets are met without excessive lowering. - Assess renal function before initiation and periodically: adjust therapy if creatinine rises. - Check serum electrolytes: watch for potassium and sodium abnormalities. - Use with caution in elderly patients: increased sensitivity to volume depletion. - Contraindicated in pregnancy: safety category unknown; avoid use. - Store at room temperature: keep in the original pack, protect from moisture.

Irbesartan plus Hydrochlorothiazide can interact with other medicines; awareness of the interaction level guides management.

Major Interactions (Avoid): - Aliskiren: combined use may increase risk of renal impairment. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - ACE inhibitors: additive effects on potassium and renal function.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response and affect renal function. - Antidiabetic agents: blood‑glucose control may change; monitor glucose levels.